Innova Captab IPO: A Game-Changing Opportunity for Investors! 💰💼
The highly anticipated IPO of healthcare company Innova Captab has finally arrived, opening on December 21st. With this IPO, the company aims to raise a whopping 570 crores rupees. Investors have the opportunity to place their bids until December 26th.
Price Band: Exciting Range for Investors! 📈📉
The price band for Innova Captab’s IPO has been set between 426 rupees and 448 rupees per share. The IPO will issue 320 crores worth of new shares and 250 crores worth of shares through an offer-for-sale. The company has reserved 50% of the allocation for retail investors, 35% for qualified institutional buyers, and 15% for high net worth individuals.
Lot Size: Grab Your Share! 📦💼
Investors must purchase a minimum of 33 shares in order to participate in the IPO. Retail investors can bid for a maximum of 13 lots or a total of 429 shares. The minimum bid amount for retail investors is 14,784 rupees, while the maximum bid amount is 1,92,192 rupees.
Key Dates: Mark Your Calendar! 🗓️📝
The shares will be allotted on December 26th, and unsuccessful investors will receive their refunds on December 28th. The shares will be transferred to the demat accounts on the same day. Innova Captab’s shares will be listed on the BSE and NSE on December 28th.
Impressive Listing Potential: A Lucrative Opportunity! 💸💼
Innova Captab’s IPO has shown strong listing potential with a current grey market premium of 211 rupees. If this trend continues on the listing day, investors could potentially earn a hefty profit of 47.1%. The shares are expected to list at a price of 659 rupees on the BSE and NSE.
Utilization of Funds: A Strategic Approach! 💼📊
The funds raised through this IPO will primarily be used to repay a loan of 186 crores rupees. Additionally, some funds will be allocated towards meeting working capital requirements and fulfilling corporate objectives.
Don’t miss out on the opportunity to invest in Innova Captab’s IPO! Grab your share and potentially earn significant returns. Stay tuned for the exciting listing on December 28th! 🎉💼
Disclaimer: This is News Coverage with Opinions of Experts and Should Not Be Taken as Direct Market Buying Tip. Market is always subject to risk. We recommend taking our content as research before investing.
